Tanabe Pharma

News

LEO Pharma is betting up to $435m on a pill that could give people with an ultra-rare light sensitivity disorder a way to spend more time outdoors.

News

Eli Lilly's first major readout at ESMO comes from a phase 1 trial of its FRα-targeting sofe-m in platinum-sensitive ovarian cancer (PSOC).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.